Videos
Femtech in the Spotlight — An Interview with Wolfgang Hackl — Founder and CEO of OncoGenomX
July 11, 2022
Eva von Mühlenen (Advisor, Geneva) and Josefine Sommer (Senior Managing Associate, Brussels) interviewed Wolfgang Hackl, founder of OncoGenomX, a Femtech startup that guides doctors in the treatment of breast cancer — about regulation, research and development (R&D), and the vast potential of artificial intelligence in the field of health technology for women.
Contacts
Related Resources
Related Blogs
Capabilities
Related Pages
Suggested News & Insights
Sidley Healthcare Investment Conference 2026Tuesday, September 22, 2026Swiss MedTech 2026Tuesday, August 25, 2026Bay Area Life Sciences RoundtableWednesday, July 22, 2026Sidley Represents Abbisko Therapeutics in Its US$1.9 Billion Strategic Collaboration With Eli Lilly and Co.July 2, 2026Sidley Represents Caidya in Strategic Combination with Simbec-OrionJune 30, 2026Sidley Represents Bio-Techne in Its US$11.3 Billion Acquisition by Merck KGaAJune 25, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory